• Emel Uyar, Alparslan Merdin, Serdar Yamanyar, Mehmet Can Ezgü, Cumhur Artuk, Gürhan Taşkın, Yakup Arslan, and Serkan Ceritli.
• Department of Critical Care Medicine, University of Health Sciences, Gülhane Education Research Hospital, Ankara, Turkey
• Turk J Med Sci. 2021 Jun 28; 51 (3): 939946939-946.

Background And AimCreating potential clinical markers for risk assessment in patients with COVID-19 continues to be an area of interest. In this study, we aimed to evaluate whether serum albumin level and thrombocyte/lymphocyte ratio are related to the severity of the disease.Materials And MethodsThe patients were divided into two groups according to the severity of disease. Demographic data, serum albumin value, lymphocyte count, TLO-1 values (thrombocyte/lymphocyte ratio-1), the highest thrombocyte count during hospitalization, TLO-2 (thrombocyte/lymphocyte ratio-2) values formed by the highest thrombocyte count, were recorded.ResultsThere was no statistically significant differences (P > 0.05) in terms of sex, thrombocyte count at the time of admission, and highest thrombocyte count during hospital follow-up. There were statistically significant differences in terms of age, comorbidity, lymphocyte value at the time of hospitalization, lymphocyte count during hospital follow-up, TLO 1, TLO 2, and serum albumin values between the groups. The ICU group were found to be older, had higher rates of comorbidity, lower lymphocyte values, higher TLO 1-2, and lower serum albumin levels (P < 0.05).ConclusionTLO-2 ratio above 260 and lymphocyte level below 1 103 cells/μL, would be a predictor of further intensive care unit need.This work is licensed under a Creative Commons Attribution 4.0 International License.

32 keywords...

hide…